Erion Dobi
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 17
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 3
- Lung Cancer Research Studies 2
-
- Advanced Breast Cancer Therapies 4
- Prostate Cancer Treatment and Research 3
- Co-authors
- Xavier Pivot (22 shared papers)L. Chaigneau (22 shared papers)Fernando Bazán (18 shared papers)Stéfano Kim (8 shared papers)Antoine Thiery-Vuillemin (12 shared papers)Martin Demarchi (7 shared papers)Cristian Villanueva (12 shared papers)Thierry Nguyen (8 shared papers)
- Journals
- BMC Cancer (3 papers)Journal of Clinical Oncology (3 papers)The Breast (2 papers)Annals of Oncology (2 papers)BMJ Supportive & Palliative Care (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Erion Dobi
32 papers receiving 377 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 96
- Oncology 156
- Pulmonary and Respiratory Medicine 114
- Hepatology 13
- Genetics 18
Countries citing papers authored by Erion Dobi
This map shows the geographic impact of Erion Dobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erion Dobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erion Dobi more than expected).
Fields of papers citing papers by Erion Dobi
This network shows the impact of papers produced by Erion Dobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erion Dobi. The network helps show where Erion Dobi may publish in the future.
Co-authors
The 25 scholars most cited alongside Erion Dobi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 44 | |
| 2 | 2023 | 43 | |
| 3 | 2012 | 36 | |
| 4 | 2011 | 24 | |
| 5 | 2022 | 19 | |
| 6 | 2014 | 19 | |
| 7 | 2015 | 19 | |
| 8 | 2013 | 17 | |
| 9 | 2015 | 16 | |
| 10 | 2016 | 16 | |
| 11 | 2019 | 15 | |
| 12 | 2012 | 15 | |
| 13 | 2012 | 14 | |
| 14 | 2015 | 13 | |
| 15 | 2013 | 10 | |
| 16 | 2013 | 9 | |
| 17 | 2014 | 8 | |
| 18 | 2022 | 6 | |
| 19 | 2012 | 5 | |
| 20 | 2025 | 5 |
About Erion Dobi
Erion Dobi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 35 papers that have together received 383 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Prostate Cancer Treatment and Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Cancer Research (96 citations), Oncology (156 citations), Pulmonary and Respiratory Medicine (114 citations), Hepatology (13 citations) and Genetics (18 citations). Erion Dobi has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Xavier Pivot, L. Chaigneau, Fernando Bazán, Stéfano Kim, Antoine Thiery-Vuillemin, Martin Demarchi, Cristian Villanueva, Thierry Nguyen, L. Cals and Christophe Borg. Their work appears in journals such as BMC Cancer, Journal of Clinical Oncology, The Breast, Annals of Oncology and BMJ Supportive & Palliative Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.